Method for treating cervical cancer
AssigneeZymoGenetics, Inc.
InventorsYasmin A. Chandrasekher, Patricia A. McKernan
Life of this patent
Estimating the term…
Abstract
Use of Interleukin-20 for treating cervical cancer or cells infected with human papilloma virus. IL-20 can be administered alone or in conjunction with radiation or chemotherapeutic agents or surgical excision of the involved cells or lesions.
Claims15
A method for inhibiting the growth and or proliferation of cervical cancer cells comprising bringing an Interleukin-20 (IL-20) polypeptide into contact with the cervical cancer cells.
A method for inhibiting the growth and or proliferation of cervical cancer cells comprising bringing a polypeptide comprising amino acid residues 33-176 of SEQ ID NO:2 into contact with the cervical cancer cells.
A method for inhibiting the growth and or proliferation of cervical cancer cells comprising bringing a polypeptide comprising amino acid residues 25-151 of SEQ ID NO:4 into contact with the cervical cancer cells.
Dependencies are inferred from the claim text.